EE522 Cost-Effectiveness of Direct Oral Anticoagulants (DOACS) Versus Low-Molecular-Weight Heparins (LMWH) in Patients with Cancer-Associated Venous Thromboembolism (CAT) in Hong Kong
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.787
https://www.valueinhealthjournal.com/article/S1098-3015(23)03917-7/fulltext
Section Title :
Section Order :
10274
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03917-7&doi=10.1016/j.jval.2023.09.787